Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0089
+0.0004 (4.71%)
At close: Apr 15, 2026
Evofem Biosciences Market Cap
Evofem Biosciences has a market cap or net worth of $1.18 million as of April 15, 2026. Its market cap has increased by 18.24% in one year.
Market Cap
1.18M
Enterprise Value
60.50M
Revenue
20.18M
Ranking
n/a
PE Ratio
25.00
Stock Price
$0.01
Market Cap Chart
Since January 18, 2018, Evofem Biosciences's market cap has decreased from 215.21M to 1.18M, a decrease of -99.45%. That is a compound annual growth rate of -46.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 1.18M | -1.99% |
| Dec 31, 2025 | 1.20M | 7.24% |
| Dec 31, 2024 | 1.12M | -12.37% |
| Dec 29, 2023 | 1.28M | -83.76% |
| Dec 30, 2022 | 7.89M | -87.13% |
| Dec 31, 2021 | 61.26M | -68.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avenue Therapeutics | 1.48M |
| inTerra Resources | 1.47M |
| Carisma Therapeutics | 1.43M |
| Clearside Biomedical | 1.39M |
| LakeShore Biopharma | 1.28M |
| Sorrento Therapeutics | 1.25M |
| CERo Therapeutics Holdings | 1.18M |
| Lyra Therapeutics | 1.15M |